Sandoz Inc. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Sandoz Inc. - Product Pipeline Review - 2014" provides data on the Sandoz Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Sandoz Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Sandoz Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Sandoz Inc. - Brief Sandoz Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sandoz Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sandoz Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sandoz Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Sandoz Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sandoz Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sandoz Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sandoz Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sandoz Inc. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sandoz Inc. Snapshot 5
Sandoz Inc. Overview 5
Key Information 5
Key Facts 5
Sandoz Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Sandoz Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Sandoz Inc. - Pipeline Products Glance 12
Sandoz Inc. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Sandoz Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Sandoz Inc. - Drug Profiles 15
adalimumab biosimilar 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
etanercept biosimilar 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
pegfilgrastim biosimilar 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
rituximab biosimilar 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Product-0405 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Sandoz Inc. - Pipeline Analysis 20
Sandoz Inc. - Pipeline Products by Therapeutic Class 20
Sandoz Inc. - Pipeline Products by Target 21
Sandoz Inc. - Pipeline Products by Route of Administration 22
Sandoz Inc. - Pipeline Products by Molecule Type 23
Sandoz Inc. - Pipeline Products by Mechanism of Action 24
Sandoz Inc. - Recent Pipeline Updates 25
Sandoz Inc. - Dormant Projects 26
Sandoz Inc. - Company Statement 27
Sandoz Inc. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Sandoz Inc. - Key Manufacturing Facilities 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables
Sandoz Inc., Key Information 5
Sandoz Inc., Key Facts 5
Sandoz Inc. - Pipeline by Indication, 2014 7
Sandoz Inc. - Pipeline by Stage of Development, 2014 8
Sandoz Inc. - Monotherapy Products in Pipeline, 2014 9
Sandoz Inc. - Partnered Products in Pipeline, 2014 10
Sandoz Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Sandoz Inc. - Phase III, 2014 12
Sandoz Inc. - Phase II, 2014 13
Sandoz Inc. - Phase I, 2014 14
Sandoz Inc. - Pipeline by Therapeutic Class, 2014 20
Sandoz Inc. - Pipeline by Target, 2014 21
Sandoz Inc. - Pipeline by Route of Administration, 2014 22
Sandoz Inc. - Pipeline by Molecule Type, 2014 23
Sandoz Inc. - Pipeline Products by Mechanism of Action, 2014 24
Sandoz Inc. - Recent Pipeline Updates, 2014 25
Sandoz Inc. - Dormant Developmental Projects,2014 26
Sandoz Inc., Other Locations 28
Sandoz Inc., Subsidiaries 28
Sandoz Inc., Key Manufacturing Facilities 29